Simpson Thacher, Khaitan & Co, Holland & Knight, Dhinal Shah Associates, and Richards Layton & Finger (RLF) advised on Amneal Pharmaceuticals’ acquisition of Kashiv BioSciences.

Amneal Pharmaceuticals has entered into an agreement to acquire 100% of Kashiv BioSciences in a transaction comprising US$375 million in cash and US$375 million in Amneal stock, along with up to US$350 million in milestone-based payments and potential royalties tied to commercial performance.

Amneal is a diversified global biopharmaceutical company focused on generic, specialty and biosimilar medicines, while Kashiv is a vertically integrated biopharmaceutical company with commercial and advanced clinical-stage assets.

Simpson Thacher is representing Amneal Pharmaceuticals, Inc. On the transaction.

The team includes Jakob Rendtorff, Benjamin Bodurian, Dan Kim, Derrick Ray, Daniel Song and Andrés Cruz (M&A); Richard Fenyes (Corporate); Vanessa Burrows, Alison Peters and Jacob Madden (Healthcare); Andrew Purcell and Shareef Salfity (Tax); Jamin Koslowe, Ashlie Lawton, Josh Goldman and Marie Gesellschap (Executive Compensation & Employee Benefits); Alysha Sekhon and Christian Bond (Intellectual Property); Karen Hsu Kelley and Brandon Adoni (Public Company Advisory Practice); Mark Skerry, Austin Lowe and Feven Yohannes (FDI); Peter Guryan and Allison Davido (Antitrust); Carleigh Rodriguez and Erin Magoffie (Environmental); Krista McManus (Real Estate); Abram Ellis, Christine Tillema and Brian Japari (Regulatory); Steven DeLott (Insurance); and Leah Malone and Chayla Sherrod (Sustainability & ESG).

Khaitan & Co is representing Amneal Pharmaceuticals as India counsel on the acquisition.

The core team comprised Rabindra Jhunjhunwala, Sameer Sah, Aman Anand, Sayani Bhattacharyya and Manya Chugh with assistance from Ritu Shaktawat and Rahul Jain (Direct Tax), Vinay Joy and Srishti Ramkrishnan (Employment law), Sudipta Bhattacharjee (Indirect Tax), Shailendra Bhandare (Intellectual Property), Mudit Shah (Real Estate), Anisha Chand (Antitrust law), Krishnendu Sen (Banking & Finance) and Harsh Walia and Shobhit Chandra (Data Privacy).

Holland & Knight represented Kashiv BioSciences LLC on the transaction.

The firm’s representation was led by Partners Amy Leder and Charles Weiss. They were assisted by Partners John Dierking, Marc Druckman, Alan Schwartz and Victoria Zerjav, and Associates Anush Yegyazarian and Max Lubin.

Dhinal Shah Associates acted as India legal advisor to Kashiv BioSciences LLC.

Richards, Layton & Finger acted as legal advisor to the committee of independent directors of the board of directors of Amneal Pharmaceuticals, Inc.